Special Issue "The Progress on Pharmaceutics in Drug Delayed Release System"

Guest Editor
Prof. Dr. Neal M. Davies
Faculty of Pharmacy, University of Manitoba, Apotex Centre, 750 McDermot Avenue, Winnipeg, Manitoba R3E OT5, Canada
Website: http://www.umanitoba.ca/faculties/pharmacy
E-Mail: Neal_Davies@umanitoba.ca
Phone: +1 509 335 4754
Fax: +1 509 335 5902
Interests: pharmacokinetics; chirality; formulation and drug delivery and physical characterization of drugs and dosage forms

Dear Colleagues,

It is often important to maintain therapeutic plasma concentrations for drugs exhibiting a short terminal half-life; for this, dosage forms with a lower input rate have been developed and pharmaceutical manufacturing of controlled, extended, and sustained release formulations have developed and evolved. With the advent of a variety of new delivery platforms and systems, formulations, biomaterials, technologies and a plethora of exciting selected therapeutic approaches significant progress on the pharmaceutics of drug delayed release systems has ensued. Therapeutic delivery of macromolecules is evolving with the aim of controlling absorption, distribution, metabolism, and cellular uptake through programmed drug delivery. Specifically, drug targeting by carriers utilizing pro-drugs, synthetic polymers, lipids, and various nanocarrier approaches is becoming more frequently incorporated into drug controlled release systems. This alteration and manipulation of input and output rates of drugs is becoming increasingly complex and drug delivery has evolved in advancing and altering release. This special issue serves to highlight and capture  a variety of advances and illustrate the remaining challenges of contemporary progress in the pharmaceutics of drug modified release systems. We invite articles on all aspects of pharmaceutics in drug delayed release systems for this special issue.

Prof. Dr. Neal M. Davies
Guest Editor

Submission

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. Papers will be published continuously (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are refereed through a peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed Open Access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 500 CHF (Swiss Francs). English correction and/or formatting fees of 250 CHF (Swiss Francs) will be charged in certain cases for those articles accepted for publication that require extensive additional formatting and/or English corrections.

• drug delivery
• drug release
• drug formulation
• dosage forms
• Nanocarrier technologies
• Sustained release
• Lipids
• polymers
• delayed release
• modified release
• biomaterials